Reaction
Silent Thyroiditis reporting signals
As of the last recalculation, Silent Thyroiditis appears in 142 FAERS reports alongside 5 co-occurring drug terms. The strongest observed disproportionality signal is PEMBROLIZUMAB (PRR 94.3).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Pembrolizumab | 46 | 94.3 | 94.4 |
| Lenvatinib | 17 | 86.2 | 86.2 |
| Ipilimumab | 21 | 83.5 | 83.6 |
| Nivolumab | 37 | 75.5 | 75.5 |
| Durvalumab | 8 | 61.0 | 61.0 |